Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of adding pioglitazone to a background regimen of empagliflozin and metformin in adults with type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)
  • PIOGLITAZONE (Pioglitazone)
  • metformin (metformin)

Snippet

Sponsor: Celltrion | Conditions: T2DM | Phase 3 | Status: ACTIVE_NOT_RECRUITING